Stockreport

Visiongain Report Provides Critical Market-led Data on the $42bn Next-Generation Biologics Market

Celyad Oncology SA - American Depositary Shares  (CYAD) 
US:NASDAQ Investor Relations: celyad.com/en/investors
PDF LONDON, Jan. 14, 2020 /PRNewswire/ -- The global next-generation biologics market is estimated to have reached $3.2bn in 2018. The market is expected to grow at a CAGR o [Read more]